CARCINOMA, OVARIAN EPITHELIAL
Clinical trials for CARCINOMA, OVARIAN EPITHELIAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, OVARIAN EPITHELIAL trials appear
Sign up with your email to follow new studies for CARCINOMA, OVARIAN EPITHELIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat ovarian cancer: major trial tests immune booster
Disease control OngoingThis large, late-stage study is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (with or without bevacizumab) works better than chemotherapy alone for women with recurrent ovarian cancer that has stopped responding to platinum-based drugs. The…
Matched conditions: CARCINOMA, OVARIAN EPITHELIAL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope to keep advanced ovarian cancer at bay
Disease control OngoingThis study aims to confirm how well a two-drug maintenance treatment works to control advanced ovarian cancer after initial chemotherapy. It will involve about 190 women whose cancer has a specific genetic marker (HRD-positive) and who responded to first-line treatment. The goal …
Matched conditions: CARCINOMA, OVARIAN EPITHELIAL
Phase: PHASE4 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope drug enters first human tests for dozens of tough cancers
Disease control OngoingThis is an early-stage study to find a safe dose of a new drug called KFA115, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced cancers that have stopped responding to standard treatments. The main goal is to check for side effects and determ…
Matched conditions: CARCINOMA, OVARIAN EPITHELIAL
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC